NEW YORK – A small subset of unselected cancer patients may carry risky germline variants in some, but not all, of their cells — cancer susceptibility mosaicism that may lead to missed pathogenic or likely pathogenic variants on available germline genetic tests, according to research presented Tuesday at the Association for Molecular Pathology virtual annual meeting.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.